Bullboard - Stock Discussion Forum Oragenics Inc OGEN

Healthcare Biotechnology

Oragenics, Inc. is a development-stage company. It is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. It is focused on nasal delivery of pharmaceutical medications in neurology and fighting infectious diseases, including drug candidates for treating mild traumatic brain injury (mTBI or Concussion), and for... see more

Add To Watchlist

NYSEAM:OGEN - Post Discussion

Oragenics Inc > Oragenics, Inc. Preparing for Phase II Clinical Trials to Tr

View:

Post by whytestocks on Feb 05, 2024 6:00pm

Oragenics, Inc. Preparing for Phase II Clinical Trials to Tr

BREAKING NEWS: $OGEN Oragenics, Inc. Preparing for Phase II Clinical Trials to Treat ConcussionOragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal nanoparticle pharmaceuticals for the treatment of neurological disorders, today announced it is preparing for a Phase II clinical trial using its novel drug - device combination for the treatment of mild Tra...OGEN - Oragenics, Inc. Preparing for Phase II Clinical Trials to Treat Concussion